As of June 30, 2026, Tata Chemicals Limited carries a market capitalization of 182.39B, placing it among publicly traded companies globally. Its enterprise value stands at 182.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 182.39B |
| Enterprise Value | 182.39B |
Tata Chemicals Limited's next confirmed earnings release is scheduled for October 30, 2026.
| Earnings Date | 10/30/2026 |
As of June 30, 2026, Tata Chemicals Limited has 254.76M shares outstanding.
| Shares Outstanding | 254.76M |
These figures are as of June 30, 2026.
| PS Ratio | 1.22 |
These figures are as of June 30, 2026. The EV/Sales ratio of 1.22 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 182.39B versus a market cap of 182.39B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 1.22 |
These figures are as of June 30, 2026.
| Interest Coverage | -0.11 |
These figures cover the twelve months ended June 30, 2026. The company generates approximately 10.42M in revenue per employee across its workforce of 14,355.50, a quick read on workforce productivity versus industry peers.
| Revenue Per Employee | 10.42M |
| Employee Count | 14,355.50 |
Over the twelve months ended June 30, 2026, Tata Chemicals Limited recorded 2.24B in income tax expense. The company reported a pretax loss of -15.85B and -19.90B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 2.24B |
As of the close on October 22, 2026, Tata Chemicals Limited's stock has declined approximately 34.92% over the past 52 weeks. The 50-day moving average sits at 641.67, while the 200-day moving average is 695.49.
| 52-Week Price Change | -34.92% |
| 50-Day Moving Average | 641.67 |
| 200-Day Moving Average | 695.49 |
Over the twelve months ended June 30, 2026, Tata Chemicals Limited generated 149.62B in revenue and converted that into -19.90B in net income, yielding earnings per share of -71.07. EBITDA reached -680.00M, while operating income came in at 5.71B.
| Revenue | 149.62B |
| Gross Profit | 108.99B |
| Operating Income | 5.71B |
| Pretax Income | -15.85B |
| Net Income | -19.90B |
| EBITDA | -680.00M |
| EBIT | -13.20B |
| Earnings Per Share (EPS) | -71.07 |
Over the twelve months ended June 30, 2026, Tata Chemicals Limited posted a gross margin of 72.84, reflecting its pricing power and cost economics. The operating margin of 3.82 and net profit margin of -13.30 provide insight into operational efficiency.
| Gross Margin | 72.84 |
| Operating Margin | 3.82 |
| Pretax Margin | -10.59 |
| Profit Margin | -13.30 |
| EBITDA Margin | -0.45 |
Tata Chemicals Limited's most recent stock split took place on October 4, 1995 with a 5:8 split ratio.
| Last Split Date | 10/4/1995 |
| Split Ratio | 5:8 |
Already premium?